According to the findings of a new study, side effects of the testosterone product AndroGel may cause older men to face an increased risk of experiencing serious prostate problems. In a study published in the Journal of Sexual Medicine, researchers from Harvard and AbbVie Inc., the manufacturer of the controversial testosterone gel, examined the levels of prostate-specific antigens (PSAs) in men using AndroGel, a popular type of testosterone replacement therapy. While most men involved in the study appeared to be unaffected by the testosterone gel, men over the age of 60 who used AndroGel had high levels of PSAs, which have been linked to an increased risk of prostate cancer and other prostate risks. If you believe you have been harmed by side effects of AndroGel, contact an experienced AndroGel attorney today for legal help.
The testosterone therapy study involved 274 men with low testosterone levels associated with a condition called hypogonadism, 234 of whom used AndroGel for six months, and 40 of whom were given a placebo. The researchers indicated in their report that, while many of the study participants experienced a slight increase in PSAs, those over the age of 60 experienced a much more significant PSA increase, compared to the younger study participants. This new study comes amid increasing concerns about the risk of cardiovascular side effects among men using testosterone replacement therapy products like AndroGel, following the release of two recent studies, each of which highlights the potential complications associated with low T products.
In November 2013, a study published in the Journal of the American Medical Association found that testosterone drugs and other products were associated with a greater risk of strokes, heart attacks and death among older men with certain pre-existing heart conditions. In another study published in the journal PLOSOne in January 2014, researchers found that low T treatments may double the risk of heart attack for younger men with heart disease, and for men over the age of 65, regardless of any pre-existing heart conditions. Following the publication of these two studies, the FDA launched its own investigation into the alleged side effects of testosterone therapy, examining the potential for the products to cause severe cardiovascular problems in men.
AbbVie Inc. currently faces a growing number of AndroGel lawsuits filed on behalf of former users, who believe that they have been adversely affected by the testosterone product. According to allegations raised in the complaints, the manufacturing company promoted AndroGel without providing consumers or the medical community with adequate warnings about the potential risk of heart problems from the testosterone replacement therapy. If you have suffered a heart attack, stroke, or prostate problem, and you believe AndroGel to be the cause, our consumer advocates at the Consumer Justice Foundation can help. We are committed to protecting the rights of consumers harmed by dangerous medications, and can help put you in touch with a reputable AndroGel lawyer today.